La intención Vytrus Biotech de saltar al BME Growth

from Biotecnología Capital · host Capital Radio

Hablamos con Albert Jané, co CEO de Vytrus Biotech, para que explique por qué quieren cotizar en bolsa y también de los proyectos de su compañía.

Episode metadata supplied by the publisher feed · Published Jan 31, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

La intención Vytrus Biotech de saltar al BME Growth

0:00 30:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

Apr 5, 2026 ·67m

Mar 22, 2026 ·134m

Mar 1, 2026 ·83m

Feb 1, 2026 ·153m

Jan 25, 2026 ·116m

Dec 14, 2025 ·73m

No similar podcasts found.

This episode is 30 minutes long.

This episode was published on January 31, 2022.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!